FLOLIPID

PeakSM

simvastatin

NDAORALSUSPENSION
Approved
Apr 2016
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
20

Clinical Trials (5)

NCT06948747Phase 1Completed

A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

Started May 2025
49 enrolled
Healthy Participants
NCT05771675Phase 1Recruiting

Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis

Started Oct 2024
90 enrolled
Recurrent Acute PancreatitisChronic Pancreatitis
NCT06207682Phase 1Completed

Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of Simvastatin

Started Jun 2022
32 enrolled
Healthy Volunteers
NCT03801733Phase 1Completed

Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin

Started Jun 2018
NCT03174041Phase 1Completed

A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin

Started Apr 2017
63 enrolled
Healthy Participants

Loss of Exclusivity

LOE Date
Feb 23, 2030
48 months away
Patent Expiry
Feb 23, 2030

Patent Records (2)

Patent #ExpiryTypeUse Code
10300041
Apr 26, 2027
Product
9597289
Feb 23, 2030
Product